CYTX

4:06 pm Cytori Therapeutics announces that Christopher Calhoun, CEO and Director of Cytori Therapeutics, is retiring from the position of CEO of the co, effective immediately

moreView todays social media effects on CYTXView the latest stocks trending across Twitter. Click to view dashboardSee who Cytori is hiring next, click here to view […]

Cytori Therapeutics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Third, we continue to generate increasing demand for our products and services. And fourth, we strengthen our cash position and balance sheet, bringing in approximately $35 million without going to the … moreView todays social media effects on CYTXView the latest stocks trending across Twitter. Click to view dashboardSee who Cytori is hiring next, click here […]

Japan’s Bold Initiative in Regenerative Medicine and Who the Big Winners Might Be

[Accesswire] – Like many other regions in the world, Japan is facing a demographic problem that threatens to pose enormous challenges for their national healthcare system in the years ahead, as the elderly segment of … moreView todays social media effects on CYTXView the latest stocks trending across Twitter. Click to view dashboardSee who Cytori is hiring next, click here […]

Japan’s Bold Initiative in Regenerative Medicine and Who the Big Winners Might Be

[Accesswire] – Like many other regions in the world, Japan is facing a demographic problem that threatens to pose enormous challenges for their national healthcare system in the years ahead, as the elderly segment of … moreView todays social media effects on CYTXView the latest stocks trending across Twitter. Click to view dashboardSee who Cytori is hiring next, click here […]

Showtime for Stem Cells at San Diego Biotechs

[at noodls] – Gail Naughton, CEO of San Diego’s Histogen, hods a miniature version of her company’s system for growing embryonic-like stem cells, derived from skin cells. Histogen is testing its stem cell technology … moreView todays social media effects on CYTXView the latest stocks trending across Twitter. Click to view dashboard […]

Cytori’s Stem Cell Therapy for Burns Wins U.S. Contract

[at noodls] – By Ryan Flinn – 2012-09-28T16:23:41Z Cytori Therapeutics Inc. (CYTX), a biotechnology company with $10 million in annual revenue, rose the most in more than a year after the company won a $4.7 million … moreView todays social media effects on CYTXView the latest stocks trending across Twitter. Click to view dashboard […]